Parabolic Drugs has entered the dosage space with an aim to make Rs 150 crore by way of sales within 3-5 years, said director Vineet Gupta.
first published: Jan 16, 2012 03:28 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Clocks Triple-Digit Gains After RBI Rate Cut But Logs Losses For The Week| Closing Bell Live
LIVE: RBI Governor Sanjay Malhotra Delivers Key Monetary Policy Statement | Interest Rates & Outlook
Nifty’s Move Hinges On RBI Rate Decision; HUL, ITC Hotels In Focus| Opening Bell Live
Nifty Sideways But Holds 26,000 Ahead Of MPC Rate Decision| IT & Realty Upbeat| Closing Bell Live
